Cargando…

Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine

The low water solubility of an active pharmaceutical ingredient (aripiprazole) is one of the most critical challenges in pharmaceutical research and development. This antipsychotic drug has an inadequate therapeutic impact because of its minimal and idiosyncratic oral bioavailability to treat schizo...

Descripción completa

Detalles Bibliográficos
Autores principales: Awais, Sophia, Farooq, Nouman, Muhammad, Sharmeen Ata, El-Serehy, Hamed A., Ishtiaq, Farrah, Afridi, Mehwish, Ahsan, Hina, Ullah, Amin, Nadeem, Tariq, Sultana, Kishwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179852/
https://www.ncbi.nlm.nih.gov/pubmed/37175270
http://dx.doi.org/10.3390/molecules28093860
_version_ 1785041196094062592
author Awais, Sophia
Farooq, Nouman
Muhammad, Sharmeen Ata
El-Serehy, Hamed A.
Ishtiaq, Farrah
Afridi, Mehwish
Ahsan, Hina
Ullah, Amin
Nadeem, Tariq
Sultana, Kishwar
author_facet Awais, Sophia
Farooq, Nouman
Muhammad, Sharmeen Ata
El-Serehy, Hamed A.
Ishtiaq, Farrah
Afridi, Mehwish
Ahsan, Hina
Ullah, Amin
Nadeem, Tariq
Sultana, Kishwar
author_sort Awais, Sophia
collection PubMed
description The low water solubility of an active pharmaceutical ingredient (aripiprazole) is one of the most critical challenges in pharmaceutical research and development. This antipsychotic drug has an inadequate therapeutic impact because of its minimal and idiosyncratic oral bioavailability to treat schizophrenia. The main objective of this study was to improve the solubility and stability of the antipsychotic drug aripiprazole (ARP) via forming binary as well as ternary inclusion complexes with hydroxypropyl-β-cyclodextrin (HPβCD) and L-Arginine (LA) as solubility enhancers. Physical mixing and lyophilization were used in different molar ratios. The developed formulations were analyzed by saturation solubility analysis, and dissolution studies were performed using the pedal method. The formulations were characterized by FTIR, XRD, DSC, SEM, and TGA. The results showcased that the addition of HPβCD and LA inclusion complexes enhanced the stability, in contrast to the binary formulations and ternary formulations prepared by physical mixing and solvent evaporation. Ternary formulation HLY47 improved dissolution rates by six times in simulated gastric fluid (SGF). However, the effect of LA on the solubility enhancement was concentration-dependent and showed optimal enhancement at the ratio of 1:1:0.27. FTIR spectra showed the bond shifting, which confirmed the formation of new complexes. The surface morphology of complexes in SEM studies showed the rough surface of lyophilization and solvent evaporation products, while physical mixing revealed a comparatively crystalline surface. The exothermic peaks in DSC diffractograms showed diminished peaks previously observed in the diffractogram of pure drug and LA. Lyophilized ternary complexes displayed significantly enhanced thermal stability, as observed from the thermograms of TGA. In conclusion, it was observed that the preparation method and a specific drug-to-polymer and amino acid ratio are critical for achieving high drug solubility and stability. These complexes seem to be promising candidates for novel drug delivery systems development.
format Online
Article
Text
id pubmed-10179852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101798522023-05-13 Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine Awais, Sophia Farooq, Nouman Muhammad, Sharmeen Ata El-Serehy, Hamed A. Ishtiaq, Farrah Afridi, Mehwish Ahsan, Hina Ullah, Amin Nadeem, Tariq Sultana, Kishwar Molecules Article The low water solubility of an active pharmaceutical ingredient (aripiprazole) is one of the most critical challenges in pharmaceutical research and development. This antipsychotic drug has an inadequate therapeutic impact because of its minimal and idiosyncratic oral bioavailability to treat schizophrenia. The main objective of this study was to improve the solubility and stability of the antipsychotic drug aripiprazole (ARP) via forming binary as well as ternary inclusion complexes with hydroxypropyl-β-cyclodextrin (HPβCD) and L-Arginine (LA) as solubility enhancers. Physical mixing and lyophilization were used in different molar ratios. The developed formulations were analyzed by saturation solubility analysis, and dissolution studies were performed using the pedal method. The formulations were characterized by FTIR, XRD, DSC, SEM, and TGA. The results showcased that the addition of HPβCD and LA inclusion complexes enhanced the stability, in contrast to the binary formulations and ternary formulations prepared by physical mixing and solvent evaporation. Ternary formulation HLY47 improved dissolution rates by six times in simulated gastric fluid (SGF). However, the effect of LA on the solubility enhancement was concentration-dependent and showed optimal enhancement at the ratio of 1:1:0.27. FTIR spectra showed the bond shifting, which confirmed the formation of new complexes. The surface morphology of complexes in SEM studies showed the rough surface of lyophilization and solvent evaporation products, while physical mixing revealed a comparatively crystalline surface. The exothermic peaks in DSC diffractograms showed diminished peaks previously observed in the diffractogram of pure drug and LA. Lyophilized ternary complexes displayed significantly enhanced thermal stability, as observed from the thermograms of TGA. In conclusion, it was observed that the preparation method and a specific drug-to-polymer and amino acid ratio are critical for achieving high drug solubility and stability. These complexes seem to be promising candidates for novel drug delivery systems development. MDPI 2023-05-03 /pmc/articles/PMC10179852/ /pubmed/37175270 http://dx.doi.org/10.3390/molecules28093860 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Awais, Sophia
Farooq, Nouman
Muhammad, Sharmeen Ata
El-Serehy, Hamed A.
Ishtiaq, Farrah
Afridi, Mehwish
Ahsan, Hina
Ullah, Amin
Nadeem, Tariq
Sultana, Kishwar
Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine
title Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine
title_full Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine
title_fullStr Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine
title_full_unstemmed Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine
title_short Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine
title_sort enhanced solubility and stability of aripiprazole in binary and ternary inclusion complexes using hydroxy propyl beta cyclodextrin (hpβcd) and l-arginine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179852/
https://www.ncbi.nlm.nih.gov/pubmed/37175270
http://dx.doi.org/10.3390/molecules28093860
work_keys_str_mv AT awaissophia enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT farooqnouman enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT muhammadsharmeenata enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT elserehyhameda enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT ishtiaqfarrah enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT afridimehwish enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT ahsanhina enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT ullahamin enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT nadeemtariq enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine
AT sultanakishwar enhancedsolubilityandstabilityofaripiprazoleinbinaryandternaryinclusioncomplexesusinghydroxypropylbetacyclodextrinhpbcdandlarginine